Poliomyelitis: eradication in sight.
作者信息
Melnick J L
机构信息
Division of Molecular Virology, Baylor College of Medicine, Houston, Texas 77030.
出版信息
Epidemiol Infect. 1992 Feb;108(1):1-18. doi: 10.1017/s0950268800049451.
Abstract
摘要
相似文献
1
Poliomyelitis: eradication in sight.
Epidemiol Infect. 1992 Feb;108(1):1-18. doi: 10.1017/s0950268800049451.
2
Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
Pediatrics. 2015 Jan;135(1):196-202. doi: 10.1542/peds.2014-3163.
3
Anomalous observations on IPV and OPV vaccination.
Dev Biol (Basel). 2001;105:197-208.
4
Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States.
Pediatr Clin North Am. 2000 Apr;47(2):287-308. doi: 10.1016/s0031-3955(05)70208-x.
5
Eradication of poliomyelitis in the United States.
Rev Infect Dis. 1982 Sep-Oct;4(5):940-50. doi: 10.1093/clinids/4.5.940.
6
7
Perspectives on rapid elimination and ultimate global eradication of paralytic poliomyelitis caused by polioviruses.
Eur J Epidemiol. 1991 Mar;7(2):95-120. doi: 10.1007/BF00237353.
8
Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016.
MMWR Morb Mortal Wkly Rep. 2016 Sep 9;65(35):934-8. doi: 10.15585/mmwr.mm6535a3.
9
Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses.
Vaccine. 2015 Mar 24;33(13):1568-77. doi: 10.1016/j.vaccine.2015.02.013. Epub 2015 Feb 18.
10
Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016.
MMWR Morb Mortal Wkly Rep. 2015 Jul 3;64(25):699-702.
引用本文的文献
1
Evaluation of pulse polio and routine immunisation coverage: Alwar District, Rajasthan.
Indian J Pediatr. 1997 Jan-Feb;64(1):65-72. doi: 10.1007/BF02795779.
2
Peptide antisera targeted to a conserved sequence in poliovirus capsid VP1 cross-react widely with members of the genus Enterovirus.
J Clin Microbiol. 1993 May;31(5):1083-7. doi: 10.1128/jcm.31.5.1083-1087.1993.
3
Poliomyelitis control in Israel, the West Bank and Gaza Strip: changing strategies with the goal of eradication in an endemic area.
Bull World Health Organ. 1994;72(5):783-96.
4
Interrupting the transmission of wild polioviruses with vaccines: immunological considerations.
Bull World Health Organ. 1994;72(6):973-83.
本文引用的文献
1
Immunogenic potency of magnesium chloride-stabilized oral poliovaccine.
JAMA. 1963 Aug 3;185:406-8. doi: 10.1001/jama.1963.03060050084032.
2
Combined use of live and killed vaccines to control poliomyelitis in tropical areas.
Dev Biol Stand. 1981;47:265-73.
3
Polio vaccination--a review of strategies.
Trans R Soc Trop Med Hyg. 1982;76(5):575-81. doi: 10.1016/0035-9203(82)90214-0.
4
Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method.
Bull World Health Organ. 1982;60(2):253-60.
5
Clinical survey techniques to estimate prevalence and annual incidence of poliomyelitis in developing countries.
Bull World Health Organ. 1980;58(4):609-20.
6
Vaccination with inactivated poliovirus vaccine and oral poliovirus vaccine in Denmark.
Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S471-4. doi: 10.1093/clinids/6.supplement_2.s471.
7
Successful results of a program combining live and inactivated poliovirus vaccines to control poliomyelitis in Gaza.
Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S467-70. doi: 10.1093/clinids/6.supplement_2.s467.
8
Use of killed poliovirus vaccine in a routine immunization program in West Africa.
Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S463-6. doi: 10.1093/clinids/6.supplement_2.s463.
9
Poliomyelitis in India: prospects and problems of control.
Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S438-41. doi: 10.1093/clinids/6.supplement_2.s438.
10
Control of poliomyelitis in Africa.
Rev Infect Dis. 1984 May-Jun;6 Suppl 2:S433-7. doi: 10.1093/clinids/6.supplement_2.s433.
Zotero 插件